Cardiovascular disease is the leading cause of disease and death in the U.S, yet patients with faulty arteries are forced to deal with synthetic arterial grafts that degrade slowly, prompting further invasive treatment that costs patients, families, and medical personnel time and money. Ramak Khosravi, MD/PhD candidate at Yale, has come up with a method that she hopes will produce a graft that can seamlessly integrate into human bodies.